WallStSmart

Linde plc Ordinary Shares (LIN)vsMesabi Trust (MSB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Linde plc Ordinary Shares generates 230394% more annual revenue ($34.65B vs $15.04M). MSB leads profitability with a 75.3% profit margin vs 20.4%. MSB trades at a lower P/E of 29.9x. LIN earns a higher WallStSmart Score of 62/100 (C+).

LIN

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 3.3Quality: 4.0
Piotroski: 3/9Altman Z: 1.49

MSB

Hold

45

out of 100

Grade: D

Growth: 4.7Profit: 10.0Value: 5.3Quality: 6.0
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LINSignificantly Overvalued (-82.5%)

Margin of Safety

-82.5%

Fair Value

$299.52

Current Price

$527.67

$228.15 premium

UndervaluedFair: $299.52Overvalued

Intrinsic value data unavailable for MSB.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LIN3 strengths · Avg: 9.0/10
Market CapQuality
$240.24B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
20.4%9/10

Keeps 20 of every $100 in revenue as profit

Operating MarginProfitability
28.5%8/10

Strong operational efficiency at 28.5%

MSB3 strengths · Avg: 10.0/10
Return on EquityProfitability
68.0%10/10

Every $100 of equity generates 68 in profit

Profit MarginProfitability
75.3%10/10

Keeps 75 of every $100 in revenue as profit

Operating MarginProfitability
48.4%10/10

Strong operational efficiency at 48.4%

Areas to Watch

LIN4 concerns · Avg: 3.3/10
PEG RatioValuation
2.204/10

Expensive relative to growth rate

P/E RatioValuation
34.5x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

MSB4 concerns · Avg: 3.5/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Price/BookValuation
17.9x4/10

Trading at 17.9x book value

Market CapQuality
$337.84M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : LIN

The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 28.5%.

Bull Case : MSB

The strongest argument for MSB centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 75.3% and operating margin at 48.4%.

Bear Case : LIN

The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Bear Case : MSB

The primary concerns for MSB are P/E Ratio, Price/Book, Market Cap.

Key Dynamics to Monitor

LIN profiles as a mature stock while MSB is a declining play — different risk/reward profiles.

LIN carries more volatility with a beta of 0.73 — expect wider price swings.

LIN is growing revenue faster at 8.2% — sustainability is the question.

LIN generates stronger free cash flow (898M), providing more financial flexibility.

Bottom Line

LIN scores higher overall (62/100 vs 45/100), backed by strong 20.4% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Linde plc Ordinary Shares

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.

Visit Website →

Mesabi Trust

BASIC MATERIALS · STEEL · USA

Mesabi Trust, a royalty trust, is in the iron ore mining business in the United States. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?